Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Management of Left Main Coronary Artery Disease
Author(s): Gabriel Torres-Ruiz , Nuria Mallofré-Vila , Paola Rojas-Flores , et al Added: 2 years ago

Intervention

Prevention & Chronic Conditions
ECG Exercise Stress Test in Coronary Artery Disease
Author(s): Gaetano Antonio Lanza Added: 9 months ago

Guidelines & Statements
Left Main Disease: The Last Frontier for Medical Therapy in Stable CAD?
Author(s): Armin Arbab-Zadeh , Michelle Graham , Hector M Garcia-Garcia , et al Added: 5 months ago

Intervention

Prevention & Chronic Conditions
Non-invasive Coronary Functional Tests in ANOCA
Author(s): Nello Cambise , Angelo Giuseppe Marino , Fabio De Benedetto , et al Added: 1 month ago

Imaging & Diagnostics

Prevention & Chronic Conditions
2024 ESC Guidelines on Peripheral Arterial and Aortic Diseases
Author(s): Giuseppe Ferrante , Brittany A Bacallao , Francesco Gioia , et al Added: 1 year ago

Vascular Disease and Surgery
TCT Middle East 25: Evaluating CAD
Author(s): Nouf Alanazi , Alaide Chieffo , Added: 9 months ago
TCT Middle East 2025 — We are joined by Dr Nouf Alanazi, Dr Alaide Chieffo and Dr Nadia Sutton as they discuss key takeaways from the conference for the physiological assessment of coronary artery disease.The panel explores emerging paradigms in MINOCA and INOCA management, addressing the limitations of conventional approaches. They review current guideline recommendations for functional testing… View more

Guidelines & Statements

Intervention
Plaque Burden on CCTA Predicts MACE in Early CAD
Added: 5 days ago Source:  Radcliffe Vascular
A post hoc analysis of the PROMISE trial has found that quantitative coronary plaque measures derived from coronary computed tomographic angiography (CCTA) can independently predict major adverse cardiovascular events (MACE) in symptomatic patients without a known history of coronary artery disease (CAD).¹ The findings suggest that total plaque burden and noncalcified plaque burden may enhance… View more

Imaging & Diagnostics

Prevention & Chronic Conditions
Dual-pathway Inhibition versus Aspirin Monotherapy
Author(s): Dirk Sibbing , Michael J Blaha , Rajinder Chawla , et al Added: 1 year ago

Anticoagulation

Prevention & Chronic Conditions
Ticagrelor Fails Noninferiority to Prasugrel in TUXEDO-2
Added: 6 days ago Source:  Radcliffe CVRM
Written by Mirjam Boros, Radcliffe CardiologyThe optimal dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI) in high-risk patients with diabetes and multivessel disease remains a key clinical question. The TUXEDO-2 trial aimed to address this by directly comparing the efficacy and safety of ticagrelor versus prasugrel in this specific patient population… View more

Anticoagulation

Cardiovascular Renal Metabolic
AFSymposium 24: Long-Term Effects of PFA on Coronary Arteries
Author(s): Yury Malyshev Added: 2 years ago
AF Symposium 24 — Dr Yury Malyshev (Mount Sinai Hospital, US) joins us to discuss the findings from three studies focusing on the long-term effects of pulsed-field ablation (PFA) on coronary arteries.QuestionsWhat is known currently about the effect of PFA in Coronary Arteries? What is the importance of this topic?What was the study design and cohort?What are the key findings?Who are the take… View more

Electrophysiology & Arrhythmia